Psychedelic medicine (New Rochelle, N.Y.)最新文献_第2页

Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry 迷幻药商业化:新兴迷幻药产业的广泛概述

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-08-16 DOI: 10.1089/psymed.2023.0013

Jacob S. Aday, B. Barnett, Dan Grossman, K. Murnane, C. Nichols, P. Hendricks

引用次数: 0

Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States 精神科药物处方者致幻剂的使用:对健康、抑郁、焦虑的影响，以及与使用模式、报告的危害和精神状态转变的关联

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-08-07 DOI: 10.1089/psymed.2023.0030

Zachary Herrmann, Adam W. Levin, S. Cole, Sarah Slabaugh, B. Barnett, Andrew D. Penn, R. Jain, Charles Raison, Bhavya Rajanna, Saundra Jain

引用次数: 0

Letter to the Editor: What Is in a Name? The Many Meanings of “Psychedelic” 给编辑的信:名字里有什么?“迷幻”的多种含义

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-07-21 DOI: 10.1089/psymed.2023.0011

Kelley C. O'Donnell, Daniel E. Roberts, Terence H. W. Ching, Gianni Glick, N. Goldway, N. Gukasyan, Jamila Hokansen, B. Kelmendi, Stephen Ross, Mary E. Yaden, C. Pittenger

引用次数: 1

Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults 探索致幻剂的独特治疗潜力，以减少慢性羞耻感在性和性别少数的成年人

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-07-10 DOI: 10.1089/psymed.2022.0018

N. Carlisle, Haley Maria Dourron, S. MacCarthy, A. J. Zarrabi, P. Hendricks

引用次数: 0

Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder 平衡MDMA和新型MDXX类似物治疗自闭症谱系障碍的疗效和安全性

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-06-26 DOI: 10.1089/psymed.2023.0023

Harpreet Kaur, Sedat Karabulut, J. Gauld, Stephen A. Fagot, Kalee N. Holloway, Hannah E. Shaw, W. Fantegrossi

引用次数: 0

Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline. 通过同伴支持电话热线减少非临床致幻剂使用的危害。

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-06-01 DOI: 10.1089/psymed.2022.0017

Mollie M Pleet, Joshua White, Joseph A Zamaria, Rachel Yehuda

{"title":"Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline.","authors":"Mollie M Pleet, Joshua White, Joseph A Zamaria, Rachel Yehuda","doi":"10.1089/psymed.2022.0017","DOIUrl":"https://doi.org/10.1089/psymed.2022.0017","url":null,"abstract":"Introduction: A resurgence of interest in the use of psychedelics for mental health and wellness has stimulated greater experimentation with psychedelics in society. Although clinical psychedelic trials protect research participants by offering a safe setting, thorough preparation, and containment during and after ingestion of psychedelic medicines, many try these substances without the benefit of these safeguards.Materials and methods: We analyzed data gathered from 884 callers to a psychedelic helpline to determine whether a helpline model could reduce the risks associated with nonclinical psychedelics use.Results: In total, 65.9% of callers indicated that the helpline de-escalated them from psychological distress. If not for their conversation with the helpline, 29.3% of callers indicated they may have been harmed; 12.5% indicated that they may have called 911; and 10.8% indicated they may have gone to the emergency room.Conclusion: The data suggest that access to a psychedelic helpline surrounding psychedelic experiences may avert harmful outcomes and offset the burden on emergency and medical services.","PeriodicalId":74590,"journal":{"name":"Psychedelic medicine (New Rochelle, N.Y.)","volume":"1 2","pages":"69-73"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9715691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics 习得性无助作为经典致幻剂潜在的跨诊断治疗机制

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-06-01 DOI: 10.1089/psymed.2023.0010

Praachi Tiwari, Andrea P. Berghella, Ceyda Sayalı, Manoj K. Doss, F. Barrett, D. Yaden

引用次数: 0

Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model. 在多药使用模型中，Tabernanthalog 可降低海洛因和酒精的使用动机。

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-06-01 Epub Date: 2023-06-14 DOI: 10.1089/psymed.2023.0009

Jasper A Heinsbroek, Giuseppe Giannotti, Joel Bonilla, David E Olson, Jamie Peters

{"title":"Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model.","authors":"Jasper A Heinsbroek, Giuseppe Giannotti, Joel Bonilla, David E Olson, Jamie Peters","doi":"10.1089/psymed.2023.0009","DOIUrl":"10.1089/psymed.2023.0009","url":null,"abstract":"Background: The potential use of psychedelic drugs as therapeutics for neuropsychiatric disorders has been limited by their hallucinogenic properties. To overcome this limitation, we developed and characterized tabernanthalog (TBG), a novel analogue of the indole alkaloids ibogaine and 5-methoxy-N,N-dimethyltryptamine with reduced cardiac arrhythmogenic risk and a lack of classical psychedelic drugs-induced sensory alterations. We previously demonstrated that TBG has therapeutic efficacy in a preclinical model of opioid use disorder (OUD) in rats and in a binge model of alcohol drinking in mice. Alcohol is commonly co-used in ∼35-50% of individuals with OUD, and yet, preclinical models that recapitulate this comorbidity are lacking.Methodology: Here we employed a polydrug model of heroin and alcohol couse to screen the therapeutic efficacy of TBG on metrics of both opioid and alcohol seeking. We first exposed rats to alcohol (or control sucrose-fade solution) in the home-cage (HC), using a two-bottle binge protocol, over a period of 1 month. Rats were then split into two groups that underwent self-administration training for either intravenous heroin or oral alcohol, so that we could assess the impact of HC alcohol exposure on the self-administration of each substance separately. Thereafter, rats began self-administering both heroin and alcohol in the same sessions. Finally, we tested the effects of TBG on break points for heroin and alcohol in a progressive ratio test, where the number of lever presses required to obtain a single reward increased exponentially.Results and conclusion: TBG effectively reduced motivation for heroin and alcohol in this test, indicating its efficacy is preserved in animals with a history of heroin and alcohol polydrug use.","PeriodicalId":74590,"journal":{"name":"Psychedelic medicine (New Rochelle, N.Y.)","volume":"1 2","pages":"111-119"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10291736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs 加拿大致幻剂调查:特点，使用模式，在使用致幻剂的大样本人群中获取

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-04-18 DOI: 10.1089/psymed.2023.0002

Stephanie Lake, P. Lucas

引用次数: 3

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress 研究致幻剂辅助心理疗法治疗照顾者困扰的基本原理

Psychedelic medicine (New Rochelle, N.Y.) Pub Date : 2023-03-14 DOI: 10.1089/psymed.2022.0011

Noah D. Gold, Samantha K. Podrebarac, Lindsay A. White, Christina Marini, Naomi M. Simon, Mary S. Mittelman, Stephen Ross, M. Bogenschutz, Petros D Petridis

引用次数: 0